RARRES2 and metabolic syndrome: Given the sparse data on adipose tissue biology in nascent MetS, we recently reported our findings evaluating four additional novel adipokines in this cohort, including chemerin, omentin-1, resistin, and visfatin in both plasma and SAT [17].